We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics
IOVA

252 hedge funds and large institutions have $4.58B invested in Iovance Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 83 increasing their positions, 91 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $52.7M | Put options by funds: $26.5M

18% more capital invested

Capital invested by funds: $3.88B → $4.58B (+$704M)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

0.67% less ownership

Funds ownership: 96.25% → 95.58% (-0.67%)

9% less repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 91

10% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 51

2% less funds holding

Funds holding: 257 → 252 (-5)

Holders
252
Holders Change
-5
Holders Change %
-1.95%
% of All Funds
5.08%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
46
Increased
83
Reduced
91
Closed
51
Calls
$52.7M
Puts
$26.5M
Net Calls
+$26.2M
Net Calls Change
-$19.2M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$112M
2
Franklin Resources
Franklin Resources
California
+$41.6M
3
NAMA
Nikko Asset Management Americas
New York
+$23.5M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$23.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$13.4M

Top Sellers

1
PA
Perceptive Advisors
New York
-$52.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$30M
3
ACA
Avoro Capital Advisors
New York
-$25.3M
4
EAM
Eagle Asset Management
Florida
-$19.8M
5
Goldman Sachs
Goldman Sachs
New York
-$18.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
51
Principal Financial Group
Iowa
$12.2M +$24.7K +806 +0.2%
Jennison Associates
52
Jennison Associates
New York
$11.4M +$38.1K +1,243 +0.4%
SEI Investments
53
SEI Investments
Pennsylvania
$11.2M -$742K -24,190 -7%
RPAM
54
Rhenman & Partners Asset Management
Sweden
$11.2M – – –
VOYA Investment Management
55
VOYA Investment Management
Georgia
$11M +$1.18M +38,485 +13%
ACP
56
Acuta Capital Partners
California
$10.4M -$8.43M -275,000 -47%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$10.4M +$390K +12,717 +4%
UBS AM
58
UBS AM
Illinois
$9.55M -$460 -15 -0%
CC
59
Casdin Capital
New York
$9.55M +$8.89M +290,000 New
TCM
60
Tekla Capital Management
Massachusetts
$8.92M – – –
SFM
61
Sphera Funds Management
Israel
$8.33M -$2.91M -95,000 -27%
Ameriprise
62
Ameriprise
Minnesota
$8.09M +$7.2M +234,775 +2,156%
Swiss National Bank
63
Swiss National Bank
Switzerland
$8.03M +$113K +3,700 +2%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$8M +$311K +10,151 +4%
MS
65
Maven Securities
Jersey
$7.88M +$7.36M +240,000 New
PC
66
Pier Capital
Connecticut
$7.49M +$6.98M +227,564 New
MCM
67
Moore Capital Management
New York
$7.24M +$5.21M +169,982 +340%
WCM Investment Management
68
WCM Investment Management
California
$6.99M +$1.67M +54,595 +35%
WP
69
Woodline Partners
California
$6.54M +$6.09M +198,684 New
BIA
70
Biondo Investment Advisors
Pennsylvania
$6M -$9.66K -315 -0.2%
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
$5.83M +$660K +21,536 +14%
Jane Street
72
Jane Street
New York
$5.71M -$6.65M -216,990 -56%
TD Asset Management
73
TD Asset Management
Ontario, Canada
$5.67M – – –
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
$5.46M +$54.3K +1,770 +1%
OCM
75
Osterweis Capital Management
California
$5.19M +$716K +23,360 +17%
1 2
3
4 5

IOVA Hedge Fund Activity: Q3 2020 in Review

252 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Iovance Biotherapeutics (IOVA) for Q3 2020, worth a combined $4.58B — up 18% from $3.88B a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of IOVA and 46 opened new positions — a net loss of 5 holders — while 91 trimmed existing stakes and 83 added.

The largest buyer was ARK Investment Management, adding an estimated $112M. The largest seller was Perceptive Advisors, cutting an estimated $52.8M.

  • 252 institutional investors held Iovance Biotherapeutics (IOVA) as of Q3 2020, down from 257 in Q2 2020.
  • Funds reported $4.58B of Iovance Biotherapeutics stock for Q3 2020, up 18% quarter-over-quarter.
  • 46 funds opened new Iovance Biotherapeutics positions in Q3 2020 and 51 closed out, a net change of -5 holders.
  • The largest Iovance Biotherapeutics buyer in Q3 2020 was ARK Investment Management, an estimated $112M added.
  • The largest Iovance Biotherapeutics seller in Q3 2020 was Perceptive Advisors, an estimated $52.8M sold.

Based on aggregated 13F filings for Q3 2020.